Hi Noha,
We (Genotypic Technology - www.genotypic.co.in) are a Genomics services provider based in India. We have a dedicated team of 20 bioinformaticians who work with RNA and ChIP-seq data. We would be happy to talk to you about your project and provide best solutions. Please feel free to write to me at [email protected]
Thanks.
Unconfigured Ad
Collapse
X
-
transcription factors binding sites and target genes
Hi Folks ,
I have a list of about 1500 genes for Drosophila melanogaster from RNA seq data and I have to determine which genes are transcription factors in that list also I would like to get the all the TFBS for each gene and target genes regulated by specific TFs
It would be very helpful if anybody could suggest the resources, databases
Thanks in advanceTags: None
Latest Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Genome Sequencing Reveals Large, Repeat-Rich DNA in Trapdoor Spider Named for Stephen Colbert
by SEQadmin2
Started by SEQadmin2, Yesterday, 09:57 AM
|
0 responses
19 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 09:57 AM
|
||
|
Started by SEQadmin2, Yesterday, 09:51 AM
|
0 responses
11 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 09:51 AM
|
||
|
Started by SEQadmin2, 10-22-2026, 11:13 AM
|
0 responses
67 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 11:13 AM
|
||
|
Started by SEQadmin2, 10-22-2026, 10:48 AM
|
0 responses
47 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 10:48 AM
|
Leave a comment: